Proton Pump Inhibitors (PPIs) · Prilosec, Nexium, Prevacid, Protonix, Aciphex
Acid Reflux Medication Not Working? Your Genetics May Be Why
Up to 30% of GERD patients on PPIs report inadequate symptom control, and for many of them the reason is written into their DNA. CYP2C19 ultrarapid metabolizers can clear a standard PPI dose before it finishes the job.
You take your acid reflux medication every day, but the heartburn and regurgitation keep coming back. If over-the-counter or prescription proton pump inhibitors (PPIs) like omeprazole (Prilosec), esomeprazole (Nexium), or lansoprazole (Prevacid) aren't controlling your GERD, you're in good company. Up to 30% of GERD patients on PPIs report inadequate symptom control, and for many of them the reason is written into their DNA.
up to 30% of GERD patients on PPIs report inadequate symptom control
Why your acid reflux medication may not be working
You may be taking it wrong
PPIs need to be taken 30 to 60 minutes before a meal on an empty stomach to work properly. This is the single most common reason they fail. Taking a PPI with food, after a meal, or at bedtime without a meal afterwards dramatically reduces its effectiveness. The drug needs active acid production to do its job.
Once daily may not be enough
Standard PPI dosing is once daily before breakfast, but many GERD patients need twice-daily dosing (before breakfast and before dinner) for adequate symptom control. If once daily isn't working, twice daily is worth trying before switching medications.
It might not be acid
Not all reflux symptoms are caused by acid. Weakly acidic or non-acidic reflux, functional heartburn, eosinophilic esophagitis, and gastroparesis can all look like GERD but won't respond to acid suppression. If PPIs provide zero relief, the diagnosis may need to be revisited.
Lifestyle factors undermine treatment
Large meals late at night, lying down after eating, obesity, smoking, and certain foods (citrus, tomatoes, coffee, alcohol, chocolate, spicy food) can all overwhelm PPI-level acid suppression. Medication works best alongside lifestyle changes, not instead of them.
Ultrarapid metabolizers can clear a standard PPI dose from their system so quickly that standard doses may not suppress acid for a full 24 hours.
How your genetics can play a role
All the major PPIs are broken down by a single liver enzyme, CYP2C19. Your genotype for that enzyme is one of the better-validated predictors of how well a PPI will actually suppress your stomach acid, and CPIC has formal dosing guidance for it.
| Gene | What it affects |
|---|---|
| CYP2C19 | CYP2C19 breaks down all PPIs (omeprazole, esomeprazole, lansoprazole, pantoprazole, dexlansoprazole) in the liver.[1] Ultrarapid metabolizers (5 to 30% of people, more common in certain ancestries) clear PPIs from their system so quickly that standard doses may not suppress acid for a full 24 hours. Rapid metabolizers (15 to 25%) see a similar but less pronounced effect. The FDA includes CYP2C19 status in its pharmacogenomic biomarker table for PPIs.[2] |
CPIC's recommendations follow directly from this. Ultrarapid metabolizers usually need roughly double the standard starting dose, and rapid metabolizers often need a 50 to 100 percent increase, especially for H. pylori eradication or erosive esophagitis.[1] Poor metabolizers run in the opposite direction: they clear the drug slowly, so a standard dose hits harder and lasts longer. That's helpful for symptom control, but it raises the risk of long-term side effects from sustained acid suppression.[3]
Already have 23andMe, AncestryDNA, or a sequencing file? A Gene2Rx report ($5 to $49) checks your CYP2C19 status alongside over 100 other medications.
A Gene2Rx report reads your own DNA to show how it may affect your response to Omeprazole and your other medications.
Find out todayWhen to consider pharmacogenetic testing
Pharmacogenetic testing makes sense if PPIs at standard doses haven't controlled your reflux symptoms after 2 to 4 weeks of correct use, if you've failed H. pylori treatment (where inadequate acid suppression is a major cause of failure), or if you're heading into long-term PPI therapy and want to make sure you're on the right dose for your genetics before settling in for years.
What you can do next
- First, double-check that you're taking your PPI correctly: 30 to 60 minutes before a meal, on an empty stomach, every day.
- If once-daily dosing isn't cutting it, ask your doctor about twice-daily dosing before giving up on PPIs entirely.
- Consider CYP2C19 pharmacogenetic testing to find out whether you're a rapid or ultrarapid metabolizer who needs a higher PPI dose.
- Ask about rabeprazole (Aciphex). It's less dependent on CYP2C19 and tends to work better for ultrarapid metabolizers.
- If PPIs are giving you no relief at all, talk through alternative diagnoses with your gastroenterologist.
Related medications
Related guides
- Omeprazole Not Working? Why Prilosec Might Not Be Helping Your Acid Reflux
- 23andMe Drug Response: What You'll Actually See in a Report From Your Data
- 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
- AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data
- Looking for a GeneSight Alternative? Here's the Short Answer
- Looking for a Genomind Alternative? Here's What to Know
Frequently asked questions
Are all PPIs affected equally by CYP2C19 genetics?
No. Omeprazole and lansoprazole are the most affected by CYP2C19 status. Pantoprazole is moderately affected. Rabeprazole is the least dependent on CYP2C19, which often makes it a better choice for ultrarapid metabolizers. Esomeprazole (Nexium) is the S-enantiomer of omeprazole and is also affected, though somewhat less than omeprazole itself.
Can I just take a double dose of my PPI instead of getting genetic testing?
Bumping the dose is reasonable for a short trial under medical supervision, but without knowing your CYP2C19 status you're guessing. Genetic testing tells you definitively whether you're clearing the drug too fast, and roughly by how much. For long-term therapy, knowing the right dose from the start is more precise than empirical dose escalation.
Does CYP2C19 status affect H2 blockers like famotidine (Pepcid)?
No. H2 blockers work through a different mechanism and are not metabolized by CYP2C19. If PPIs aren't working because of CYP2C19 ultrarapid metabolism, H2 blockers can provide supplementary relief, though they're generally less potent than PPIs for GERD.
References
- CPIC. CPIC Guideline for Proton Pump Inhibitors and CYP2C19 (2020). cpicpgx.org
- U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
- Clinical Pharmacogenetics Implementation Consortium (CPIC). CPIC Guidelines. cpicpgx.org
Disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication. Never stop or change a medication without medical supervision.